Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Friedrich

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|October 9, 2012
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigensMatthias Friedrich, Tobias Raum, Ralf Lutterbuese, et al.
Plos One|August 20, 2015
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center CohortFabian Schnitzler, Matthias Friedrich, Johannes Stallhofer, et al.
Gastroenterology|April 5, 2021
Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal RegenerationMartijn A J Koppens, Hayley Davis, Gabriel N Valbuena, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAMFrank J Warnders, Stijn J H Waaijer, Martin Pool, et al.
Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2Simon Woelfel, Joel Dütschler, Marius König, et al.
CJC Open|December 11, 2020
The Canadian Alliance for Healthy Hearts and Minds: How Well Does It Reflect the Canadian Population?Ruth E Hall, Natasa Tusevljak, C Fangyun Wu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2026
Tools and Advanced Imaging Technologies for Assessing Intestinal Epithelial Barrier Integrity: A Systematic ReviewSophie Vieujean, Raja Atreya, Andrea Buda, et al.
Vaccines|July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|October 9, 2012
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigensMatthias Friedrich, Tobias Raum, Ralf Lutterbuese, et al.
Plos One|August 20, 2015
Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center CohortFabian Schnitzler, Matthias Friedrich, Johannes Stallhofer, et al.
Gastroenterology|April 5, 2021
Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal RegenerationMartijn A J Koppens, Hayley Davis, Gabriel N Valbuena, et al.
Oncogene|June 2, 2018
Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionHauke Stamm, Felix Klingler, Eva-Maria Grossjohann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAMFrank J Warnders, Stijn J H Waaijer, Martin Pool, et al.
Gut|March 8, 2013
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatmentCornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2022
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2Simon Woelfel, Joel Dütschler, Marius König, et al.
CJC Open|December 11, 2020
The Canadian Alliance for Healthy Hearts and Minds: How Well Does It Reflect the Canadian Population?Ruth E Hall, Natasa Tusevljak, C Fangyun Wu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2026
Tools and Advanced Imaging Technologies for Assessing Intestinal Epithelial Barrier Integrity: A Systematic ReviewSophie Vieujean, Raja Atreya, Andrea Buda, et al.
Vaccines|July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Pageof 9